Setting new standards in information exchange for the pharmaceutical and biotech industry
Rational Combinations 360° Summit Confirms Program Line-Up for September 13-14, 2018
June 15, 2018
The Conference Forum announced the agenda and speaking faculty for the 3rd Annual Rational Combinations 360° event, scheduled for September 13-14, 2018 at the Wyndham Philadelphia. The speaking faculty is committed to covering a 360° comprehensive view on business aspects, clinical advancements and scientific data for immuno-oncology combination strategies to help IO stakeholders fight a wider range of cancers.
Keynoting is Dr Steven Rosenberg, Chief of Surgery Branch, the National Cancer Institute who will discuss cancer immunotherapy using the adoptive cell transfer of autologous lymphocytes with antitumor activity with an emphasis on the identification of T-cells that recognize the products of mutations unique to the individual patient’s cancer.
Rational Combinations 360° will also feature Dr Jason Luke, the University of Chicago, who will provide a full analysis and lessons learned on the recent IDO plus Keytruda combination trial.
Lead Advisors Dr Patrick Hwu, MD Anderson Cancer Center, Dr Axel Hoos, GSK and Dr Ian McCaffery, Janssen chair the third annual Rational Combinations 360° event. They will be joined by a number of distinguished speakers including, but not limited to, Dr Roy Baynes of Merck, Dr Daniel Chen of Genentech, Dr Amanda Bruno of GSK, Dr Philip Gotwals of Novartis Institutes for Biomedical Research, Dr Michael Kalos of Janssen Oncology, Dr Maria Jure Kunkel of Medimmune, and Dr Ke Liu of the FDA.
The conference includes seven plenary sessions with data presentations and panel discussions on Discovery/Preclinical Science, Translational Science, Biomarkers and Diagnostics, Clinical Operations and Development, Business Aspects, Financial and Commercial Implications and Emerging Technologies.
“We are pleased to continue to deliver the leading industry event specializing in important updates for the community on current research in immunotherapy combinations,” said Kate Woda, Conference Director.
Rational Combinations 360° will also feature extensive networking opportunities including one-on-one partnering meetings and there will be a designated exhibit area featuring service and technology companies.